🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07401173
Recruiting Observational

DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)

NCT07401173 · tracked via the Priya Life Science China tracker
Sponsor
Qun Zhao
Phase
Observational
Started
2026-03-01
Last updated
2026-04-09

Condition(s) studied

Gastric Cancer (Diagnosis)Postoperative Complications

Study summary

Gastric cancer is a leading cause of cancer-related mortality, and radical surgery remains the primary treatment. However, postoperative complications are common and can significantly impact patient recovery and quality of life. Currently, doctors lack precise tools to accurately predict which patients are at high risk for developing severe complications before surgery.

This study aims to validate a novel artificial intelligence (AI) model called "DeepComp." The DeepComp model integrates clinical data with advanced radiomic features derived from routine preoperative CT scans. Specifically, it analyzes both the tumor characteristics and the patient's body composition (including skeletal muscle and fat distribution) to assess physiological reserve.

In this prospective, multicenter observational study, researchers will enroll patients scheduled for gastric cancer surgery across five medical centers. The DeepComp model will be used to predict the risk of moderate-to-severe postoperative complications (Clavien-Dindo grade II or higher). These predictions will then be compared with the actual clinical outcomes observed 30 days after surgery. The goal is to determine the accuracy and reliability of the DeepComp model in a real-world clinical setting, potentially providing a powerful tool for personalized surgical risk assessment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: Age ≥ 18 years. Histologically confirmed gastric adenocarcinoma. Scheduled for elective radical gastrectomy (open, laparoscopic, or robotic) with curative intent. Standard preoperative contrast-enhanced abdominal CT scans (venous phase) performed within 14 days prior to surgery. Willingness to sign informed consent. Exclusion Criteria: Emergency surgery due to perforation, obstruction, or massive bleeding. Intraoperative findings of distant metastasis (Stage IV) or unresectable disease preventing R0 resection. Concurrent or previous malignant tumors within the last 5 years (except gastric cancer). Pregnancy or lactation. Severe metallic artifacts on CT images preventing radiomic analysis.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the Fourth Hospital of Hebei Medical University Shijiazhuang None Selected Recruiting

More Qun Zhao trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07401173 on ClinicalTrials.gov ↗ ← All trials in China